Supreme Court Further Refines Proof Standards For Class Certification And Ups The Ante For Antitrust Plaintiffs
March 28, 2013
On March 27, 2013, the U.S. Supreme Court issued its long-awaited opinion in Comcast Corp. v. Behrend , addressing the quality of proof needed to satisfy Federal Rule of...
more
UK Government to redraft NHS procurement regulations
March 15, 2013
On 5 th March 2013 it was announced that the government would redraft the National Health Service (Procurement, Patient Choice and Competition) Regulations 2013 (SI...
more
UK uncovers major illicit drug mailing operation
March 8, 2013
The UK Medicines and Healthcare products Regulatory Agency (the "MHRA") has secured the conviction and imprisonment of a Portuguese national after seizing &poun...
more
UK High Court dismisses application for interim injunction in refusal to supply case
March 8, 2013
The UK High Court recently dismissed an application by Chemistree Homecare Limited ("Chemistree") for an interim injunction requiring Abbvie Limited ("Abbv...
more
Anti-Corruption Regulation in 2013 and a Review of 2012 Major Developments
March 4, 2013
In 2012, there were a number of developments in both the United States and around the globe related to anti-corruption enforcement. The U.S. and U.K. enforcement agencies...
more
|
view as PDF
J&J and Novartis Accused of Delaying Generic Entry in the Netherlands
February 8, 2013
The European Commission has accused the Dutch subsidiaries of US giant Johnson & Johnson and Swiss-based Novartis of delaying entry into the marketplace of a generic...
more
European Parliament Approves EU Unitary Patent Package
December 21, 2012
On December 11, 2012, the European Parliament announced that it has voted to approve the three pieces of legislation forming the "EU patent package", made up of...
more
The Court of Justice of the EU Rules on the Definition of ‘Medical Devices’
December 20, 2012
Recently, the Court of Justice of the European Union (the "CJEU") ruled on the referral from Germany's highest Court, the Bundesgerichtshof, in Brain...
more
European Court of Justice Refuses AstraZeneca’s Appeal Against €52.5 Million Fine for Abuse of Dominance
December 14, 2012
On December 6, 2012, the European Court of Justice ("ECJ") rejected an appeal by AstraZeneca plc against a €52.5 million fine imposed in 2010 for abuse of...
more
UK MHRA Launches New Procedure for Reclassification of Medicines
December 14, 2012
On December 6, 2012, the UK Medicines and Healthcare products Regulatory Agency ("MHRA" - the government agency responsible for ensuring that medicines and...
more
Comment Period Opens for EU Proposed Framework on Medical Device Regulation
December 7, 2012
On November 12, 2012, the UK government, through the Medicines and Healthcare products Regulatory Agency ("MHRA"), launched a consultation on the European...
more
EU Pharmacovigilance: European Commission Launches Public Consultation on Phasing-in of Symbol Identifying Medicines Under Additional Monitoring
December 7, 2012
The European Commission (the "Commission") has opened a public consultation on phasing-in a black symbol identifying medicines which are subject to additional...
more
Competition & Privacy in Markets of Data
November 26, 2012
Pamela Jones Harbour, a partner at Fulbright and Jaworski addressed the European Parliament in Brussels on Monday, November 26, 2012. She spoke on "Competition and...
more
|
view as PDF
EU Commission approves acquisition of Teva's over the counter business by Procter & Gamble
November 23, 2012
The European Commission (the "Commission") has cleared Procter & Gamble's ("P&G") acquisition of the over-the-counter business of Israeli...
more
Fulbright & Jaworski L.L.P. and Norton Rose Analyze the Much-Anticipated FCPA Guidance
November 16, 2012
Pages(6):
1 | 2 | 3 | 4 | 5 | >>
Last ...
On November 14, 2012, the U.S. Department of Justice ("DOJ") and U.S. Securities and Exchange Commission ("SEC") released the long-awaited Foreign...
more
